HYNR-CS inj

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
2	筋萎縮性側索硬化症	3

2. 筋萎縮性側索硬化症

臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225

trials per page:

Showing 1 to 3 of 3 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03214146 (ClinicalTrials.gov)	February 1, 2017	9/7/2017	Safety/Efficacy Study of 2nd Cycle Treatment After 6 Months of 1st Cycle HLA-haplo Matched Allogenic ...	An Open-label, Phase 1 Trial for Safety and Efficacy Study of 2nd Cycle Treatment After 6 Months of ...	Amyotrophic Lateral Sclerosis	Biological: HYNRCS-Allo inj	Hanyang University Seoul Hospital	Corestem, Inc.	Active, not recruiting	25 Years	80 Years	All	6	Phase 1	Korea, Republic of
2	NCT01758510 (ClinicalTrials.gov)	December 2012	10/12/2012	Safety Study of HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in Amyotrophic L ...	An Open-label, Phase 1 Trial for Safety Study of HLA-haplo Matched Allogenic Bone Marrow Derived Ste ...	Amyotrophic Lateral Sclerosis;Motor Neuron Disease;Neuromuscular Disease;Neurodegenerative Disease;C ...	Genetic: HYNR-CS-Allo	Hanyang University Seoul Hospital	Corestem, Inc.	Completed	25 Years	80 Years	All	6	Phase 1	Korea, Republic of
3	NCT01363401 (ClinicalTrials.gov)	February 2011	30/5/2011	Safety and Efficacy Study of Autologous Bone Marrow Derived Stem Cell Treatment in Amyotrophic Later ...	An Open-label, Phase I/II Trial for Safety and Efficacy Study of Autologous Bone Marrow Derived Stem ...	Amyotrophic Lateral Sclerosis;ALS	Biological: HYNR-CS inj;Other: Control group	Corestem, Inc.	NULL	Completed	25 Years	75 Years	All	72	Phase 1/Phase 2	Korea, Republic of

First Previous1Next Last